510(k) K180209
K180209 is an FDA 510(k) premarket notification submitted by Diazyme Laboratories, Inc. for the device "Diazyme 1,5-AG Assay". The FDA issued a decision of Substantially Equivalent on October 4, 2018. The device falls under product code NOZ (Assay, 1,5-Anhydroglucitol (15ag)), a Class II device regulated under 21 CFR 864.7470. Diazyme Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 4, 2018
- Date Received
- January 24, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Assay, 1,5-Anhydroglucitol (15ag)
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type
The test provides quantitative measurement of 1,5-anhydroglucitol (15AG) in patient's blood. The test is for professional use, and is indicated for the monitoring of glycemic control in people with diabetes.